MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia

Haematologica

Volumn 99, Issue 8, 2014, Pages 1326-1333

  Mets, Evelien ^a   Van Peer, Gert ^a   Van der Meulen, Joni ^a   Boice, Michael ^b   Taghon, Tom ^a   Goossens, Steven ^c,d   Mestdagh, Pieter ^a   Benoit, Yves ^a   De Moerloose, Barbara ^a   Van Roy, Nadine ^a   Poppe, Bruce ^a   Vandesompele, Jo ^a   Wendel, Hans Guido ^b   Van Vlierberghe, Pieter ^a   Speleman, Frank ^a   Rondou, Pieter ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 128 3P; MICRORNA 20A; MICRORNA 26A; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; CARRIER PROTEIN; MIRN128 MICRORNA, HUMAN; PHF6 PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; FIREFLY; GENE; GENE EXPRESSION; GENE INTERACTION; GENE REGULATOY NETWORK; GENETIC ANALYSIS; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PHF6 GENE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; ANIMAL; GENE TARGETING; GENETICS; HEK293 CELL LINE; JURKAT CELL LINE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; CARRIER PROTEINS; GENE TARGETING; HEK293 CELLS; HUMANS; JURKAT CELLS; MICE; MICE, TRANSGENIC; MICRORNAS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84905171034     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.099515     Document Type: Article

References (30)

1. De Keersmaecker K, Marynen P, Cools J. Genetic insights in the pathogenesis of Tcell acute lymphoblastic leukemia. Haematologica. 2005; 90(8): 1116-27.
2. Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010; 42(4): 338-42.
3. Grossmann V, Haferlach C, Weissmann S, Roller A, Schindela S, Poetzinger F, et al. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosomes Cancer. 2013; 52(4): 410-22.
4. Huh HJ, Lee SH, Yoo KH, Sung KW, Koo HH, Jang JH, et al. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia. Ann Hematol. 2013; 92(5): 635-44.
5. Wang Q, Qiu H, Jiang H, Wu L, Dong S, Pan J, et al. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica. 2011; 96(12): 1808-14.
6. Yoo NJ, Kim YR, Lee SH. Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma. Acta Oncol. 2012; 51(1): 107-11.
7. Todd MA, Picketts DJ. PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex. J Proteome Res. 2012; 11(8): 4326-37.
8. Wang J, Leung JW, Gong Z, Feng L, Shi X, Chen J. PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis. J Biol Chem. 2013; 288(5): 3174-83.
9. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2): 215-33.
10. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4): 259-69.
11. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med. 2009; 60: 167-79.
12. Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (TALL). Nat Genet. 2011; 43(7): 673-8.
13. Ji S, Shao G, Lv X, Liu Y, Fan Y, Wu A, et al. Downregulation of miRNA-128 sensitises breast cancer cell to chemodrugs by targeting Bax. Cell Biol Int. 2013; 37(7): 653-8.
14. Donzelli S, Fontemaggi G, Fazi F, Di Agostino S, Padula F, Biagioni F, et al. MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function. Cell Death Differ. 2012; 19(6): 1038-48.
15. Peruzzi P, Bronisz A, Nowicki MO, Wang Y, Ogawa D, Price R, et al. MicroRNA-128 coordinately targets polycomb repressor complexes in glioma stem cells. Neuro Oncol. 2013; 15(9): 1212-24.
16. Paschou M, Doxakis E. Neurofibromin 1 is a miRNA target in neurons. PLoS One. 2012; 7(10): e46773.
17. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996; 183(5): 2283-91.
18. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007; 13(5): 613-8.
19. Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007; 43(10): 1529-44.
20. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, and Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005; 435(7042): 682-6.
21. Krutzfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 2006; 4(1): 9-12.
22. Nelson PT, Keller JN. RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol. 2007; 66(6): 461-8.
23. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, et al. miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell. 2009; 35(5): 610-25.
24. Zhu YD, Wang L, Sun C, Fan L, Zhu DX, Fang C, et al. Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia. Med Oncol. 2012; 29(4): 2323-31.
25. Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly MB, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA. 2007; 104(50): 19971-6.
26. Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao H, et al. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res. 2011; 17(22): 7105-15.
27. Picker A, Jackson DB, Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine. Expert Rev Mol Diagn. 2011; 11(6): 567-77.
28. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptorpositive human breast cancer. Proc Natl Acad Sci USA. 2008; 105(35): 13021-6.
29. Schotte D, Chau JC, Sylvester G, Liu G, Chen C, van der Velden VH, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia. 2009; 23(2): 313-22.
30. Yamada N, Noguchi S, Kumazaki M, Shinohara H, Miki K, Naoe T, et al. Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia Jurkat cells by modulating expression of Fas-associated protein with death domain (FADD). Biochim Biophys Acta. 2013; 1843(3): 590-602.